Curis CEO granted 110,090 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CURIS INC President & CEO James E. Dentzer reported a compensation-related grant of employee stock options. He was awarded options to buy 110,090 shares of Curis common stock at an exercise price of $5.29 per share, expiring on July 6, 2036.
According to the filing, 25% of the original option shares vest on July 7, 2027, with an additional 6.25% of the original shares vesting each successive quarter until July 7, 2030. Following this grant, Dentzer holds options covering 110,090 underlying shares directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee stock option (right to buy) | 110,090 | $5.29 | $582K |
Footnotes (1)
- F1. The option grant described in this Form 4 filing vests as to 25% of the original shares on July 7, 2027 and as to an additional 6.25% of the original shares each successive quarter and until July 7, 2030.
Key Figures
Key Terms
Employee stock option (right to buy) financial
Common Stock financial
conversion or exercise price financial
vests financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Curis (CRIS) President & CEO James E. Dentzer report on this Form 4?
What is the exercise price and expiration date of the Curis (CRIS) CEO’s stock options?
How do the newly granted Curis (CRIS) options vest for the CEO?
Is this Curis (CRIS) Form 4 an open-market stock purchase or sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.